A randomized, placebo-controlled study of givosiran in patients with acute hepatic porphyrias (ENVISION): Final (36-month) analysis of the Taiwan Cohort.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- December 2, 2023